Publications - IR Sant Pau

Search

01/06/2025 Factors associated with the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors after an episode of acute heart failure and prognostic impact

Llorens, P, Haro, A, Gil, V, Alquézar-Arbé, A, Jacob, J, Espinosa, B, de la Torre, MAG, Núñez, J, Rossello, X, Miró, O. Factors associated with the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors after an episode of acute heart failure and prognostic impact. REVISTA CLINICA ESPANOLA. 2025; 225(6)DOI:10.1016/j.rce.2025.502300. PMID:40316136. IF:1.700(Q2/4D).

01/06/2025 Use of Standardized Dosing Sheets in Pediatric Emergency Care: Experience in a Third-Level Hospital

Serralabós-Ferré, J, Castillo-Gomez, F, Sensarrich-Roset, M, Barceló-Carceller, I, Gonzalez-Rioja, X. Use of Standardized Dosing Sheets in Pediatric Emergency Care: Experience in a Third-Level Hospital. CLINICAL PEDIATRICS. 2025; 64(6)DOI:10.1177/00099228241301842. PMID:39660385. IF:0.700(Q4/8D).

01/06/2025 Anatomical and functional results of injectable plasma rich in growth factors as a treatment for poor prognosis macular holes

Caminal, M, Crespi, J, Rego, D, Oribio, C, Saladrigas, A, Conversa, S, Cobo, M, Díaz-Cascajosa, J, Vela, JI. Anatomical and functional results of injectable plasma rich in growth factors as a treatment for poor prognosis macular holes. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2025; 66(8)DOI:. PMID:. IF:4.700(Q1/1D).

01/06/2025 Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL Study

Augustin, M, Serra-Baldrich, E, Seneschal, J, Grond, S, Lampropoulou, A, Elrayes, M, Ogwu, S, de la Torre, I, Bewley, A, Pinter, A. Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL Study. ADVANCES IN THERAPY. 2025; 42(6)DOI:10.1007/s12325-025-03137-3. PMID:40192965. IF:4.000(Q1/3D).

01/06/2025 Cholinergic Pruritus as an Early Sign of Essential Thrombocythemia With Therapeutic Response to Ruxolitinib

Mateu-Arrom, L, Serra-Baldrich, E, Puig, L. Cholinergic Pruritus as an Early Sign of Essential Thrombocythemia With Therapeutic Response to Ruxolitinib. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2023.09.035. PMID:39947585. IF:(Q/D).

01/06/2025 Current Challenges in Dermatology Residency Training

Ferrer, AL. Current Challenges in Dermatology Residency Training. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2025.03.021. PMID:. IF:(Q/D).

01/06/2025 Cardioprotection During Myocardial Infarction in Diabetic Cardiomyopathy

Alcover, S, López, S, Ramos-Regalado, L, Muñoz-García, N, Gallinat, A, Suades, R, Badimon, L, Vilahur, G. Cardioprotection During Myocardial Infarction in Diabetic Cardiomyopathy. DIABETES. 2025; 74(6)DOI:10.2337/db24-0510. PMID:40080393. IF:7.500(Q1/1D).

01/06/2025 Primary cutaneous rhabdomyosarcoma with EWSR1/FUS::TFCP2 fusion: four new cases with distinctive morphology, immunophenotypic, and genetic profile

Machado, I, Wardelmann, E, Zhao, M, Song, J, Wang, YL, Braun, SA, Catasús, L, Ferré, M, Leoveanu, I, Westhoff, J, Rüdiger, T, Bagué, S. Primary cutaneous rhabdomyosarcoma with EWSR1/FUS::TFCP2 fusion: four new cases with distinctive morphology, immunophenotypic, and genetic profile. VIRCHOWS ARCHIV. 2025; 486(6)DOI:10.1007/s00428-024-04007-z. PMID:39692858. IF:3.100(Q2/3D).

01/06/2025 Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms

Gravas, S, De Nunzio, C, Pinheiro, LC, de Leon, JP, Skriapas, K, Milad, Z, Lombardo, R, Medeiros, M, Makrides, P, Samarinas, M, Gacci, M. Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms. PROSTATE CANCER AND PROSTATIC DISEASES. 2025; 28(2)DOI:10.1038/s41391-024-00857-5. PMID:38971935. IF:5.800(Q1/1D).

01/06/2025 Strategies and Techniques for Ileourethral Approximation During Robotic Intracorporeal Neobladder Reconstruction: An International Survey and Video Collection, in Collaboration with the European Association of Urology Robotic Urology Section Scientific Working Group

Sighinolfi, MC, Assumma, S, Wiklund, P, Gaston, R, Minervini, A, Mottried, A, Mehrazin, R, Canda, AE, Panio, E, Gavia, F, Sarchi, L, Calcagnile, T, Turri, F, Di Maida, F, Lambertini, L, Jhon, H, Coelho, R, Hosseini, A, Maes, K, Kumar, A, Rawal, SK, Yuvaraja, TB, Cacciamani, GE, Celia, A, Leonardo, C, Greco, F, Falabella, R, Annino, F, Galfano, A, Porreca, A, Crestani, A, Umari, P, Bertolo, R, Antonelli, A, Papalia, R, Falagario, U, Schiavina, R, Sfakianos, J, Tillub, N, Wijburg, C, Tondolo, V, Alfieri, S, Breda, A, Gaia, G, Terzoni, S, Moschovas, MC, Patel, V, Rocco, B. Strategies and Techniques for Ileourethral Approximation During Robotic Intracorporeal Neobladder Reconstruction: An International Survey and Video Collection, in Collaboration with the European Association of Urology Robotic Urology Section Scientific Working Group. European Urology Open Science. 2025; 76DOI:10.1016/j.euros.2025.03.018. PMID:40476271. IF:4.500(Q1/2D).

01/06/2025 Robotic ileal ureter replacement vs kidney autotransplantation for long ureteric strictures

Afferi, L, Gallioli, A, Territo, A, Cannoletta, D, Mestdagh, K, Vangeneugden, J, Van Praet, C, Desender, L, Mercier, J, Prudhomme, T, Salamone, V, Fontana, G, Albisinni, S, Osswald, R, John, H, Etcheverry, B, Vigués, F, Doumerc, N, Minervini, A, Palou, J, Decaestecker, K, Breda, A. Robotic ileal ureter replacement vs kidney autotransplantation for long ureteric strictures. BJU INTERNATIONAL. 2025; 135(6)DOI:10.1111/bju.16704. PMID:40066829. IF:4.400(Q1/2D).

01/06/2025 Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease

Pichlera, R, van Creija, NCH, Subielab, JD, Cimadamorec, A, Caño-Velascod, J, Tullye, KH, Mori, K, Contieri, R, Afferi, L, Marij, A, Soriak, F, Del Giudice, F, D'Eliam, C, Mayrn, R, Mertensg, LS, Pyrgidiso, N, Moschinip, M, Galliolii, A. Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease. Actas Urologicas Espanolas. 2025; 49(5)DOI:10.1016/j.acuro.2025.501719. PMID:39955055. IF:1.200(Q3/7D).

01/06/2025 Robot-assisted kidney transplantation using right- vs. left-sided grafts from living donors: a prospective multicenter study from the ERUS-RAKT working group

Pecoraro, A, Territo, A, Gallioli, A, Basile, G, Vangeneugden, J, Etcheverry, B, Era, MM, Rodriguez, BLD, Prudhomme, T, Mercier, J, Ortved, M, Chner, PZ, Volpe, A, Garcia-baquero, R, Kocak, B, Idu, M, Stockle, M, Rohrsted, M, Canda, AE, Roder, A, Alcaraz, A, Doumerc, N, Vigues, F, Decaestecker, K, Masieri, L, Serni, S, Breda, A, Campi, R. Robot-assisted kidney transplantation using right- vs. left-sided grafts from living donors: a prospective multicenter study from the ERUS-RAKT working group. Minerva Urology And Nephrology. 2025; 77(3)DOI:10.23736/S2724-6051.25.06279-2. PMID:40528772. IF:4.200(Q1/2D).

01/06/2025 Impact of opium on bladder cancer incidence: A systematic review and meta-analysis

Mancon, S, Matsukawa, A, Cadenar, A, Tsuboi, I, Miszczyk, M, Parizi, MK, Fazekas, T, Schulz, RJ, Cormio, A, Laukhtina, E, Gallioli, A, Diana, P, Contieri, R, Soria, F, Pradere, B, Lughezzani, G, Kimura, T, Territo, A, Breda, A, Buffi, NM, Hurle, R, Shariat, SF, D'Andrea, D. Impact of opium on bladder cancer incidence: A systematic review and meta-analysis. Actas Urologicas Espanolas. 2025; 49(5)DOI:10.1016/j.acuro.2025.501749. PMID:40097099. IF:1.200(Q3/7D).

01/06/2025 A Global Perspective on the Adoption of Different Robotic Platforms in Uro-Oncological Surgery

Cannoletta, D, Gallioli, A, Mazzone, E, Sopena, JMG, Territo, A, Di Bello, F, Casadevall, M, Mas, L, Mancon, S, Diana, P, Palou, J, Breda, A. A Global Perspective on the Adoption of Different Robotic Platforms in Uro-Oncological Surgery. European Urology Focus. 2025; 11(1)DOI:10.1016/j.euf.2025.03.016. PMID:40158899. IF:5.600(Q1/1D).

01/06/2025 Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain

Najjari-Jamal, D, Rovirosa, A, Gimeno-Morales, M, Majercakova, K, Sánchez, M, Garcia, S, Guevara, D, Muñoz, T, de la Fuente, C, Micó, S, Stefanovic, M, Matute, R, Córdoba, S. Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain. Clinical & Translational Oncology. 2025; 27(6)DOI:10.1007/s12094-024-03804-x. PMID:39636497. IF:2.500(Q3/6D).

01/06/2025 Mediterranean Diet and Risk of Hip Fracture: A Systematic Review and Dose-Response Meta-Analysis

Fa-Binefa, M, Clara, A, Lamas, C, Elosua, R. Mediterranean Diet and Risk of Hip Fracture: A Systematic Review and Dose-Response Meta-Analysis. NUTRITION REVIEWS. 2025; 83(6)DOI:10.1093/nutrit/nuae141. PMID:39441714. IF:4.900(Q1/2D).

01/06/2025 Translation and psychometric evaluation of the Spanish version of the Heart Failure-Specific Health Literacy

Santesmases-Masana, R, Hernández-Martínez-Esparza, E, Campillo-Zaragoza, B, Lapena-Estella, C, López, EM, Checa, C, Puig, EG, Paz, LGD. Translation and psychometric evaluation of the Spanish version of the Heart Failure-Specific Health Literacy. PATIENT EDUCATION AND COUNSELING. 2025; 135DOI:10.1016/j.pec.2025.108732. PMID:40081156. IF:3.100(Q1/1D).

01/06/2025 COMPARISON OF ACTIVITY AND REMISSION INDICES IN SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL UTILITY

Bernardez, J, Magallares, BP, Codes, H, Martínez-Martínez, L, Gich, I, Castellvi, I, Moya, P, Tandaipan, JL, Park, HS, Díaz-Torné, C, Comas, LS, García-Alija, A, Laiz, A, Fernandez-Sanchez, SP, Ros, S, Corominas, H. COMPARISON OF ACTIVITY AND REMISSION INDICES IN SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL UTILITY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2893. PMID:. IF:20.600(Q1/1D).

01/06/2025 Measurable Residual Disease in UBTF-TD Adult Acute Myeloid Leukemia

Castellet, H, Ramil, G, Carricondo, M, Oñate, G, Garrido, A, Artigas, A, Pratcorona, M, Salamero, O, Cortés-Bullich, A, Vives, S, Tormo, M, Mascaró, M, Gallardo, D, Tutusaus, JMM, Garcia, A, Sierra, J, Esteve, J, Nomdedéu, J. Measurable Residual Disease in UBTF-TD Adult Acute Myeloid Leukemia. EUROPEAN JOURNAL OF HAEMATOLOGY. 2025; 114(6)DOI:10.1111/ejh.14402. PMID:39988452. IF:2.300(Q2/5D).

01/06/2025 Delphi consensus on referral criteria for pediatric patients with suspected Dravet syndrome

Aledo-Serrano, A, Boronat, S, García-Peñas, JJ, García-Ron, A, Gil-Nagel, A, Uranga, JJR, Sánchez-Carpintero, R, Smeyers, P, Villanueva, V. Delphi consensus on referral criteria for pediatric patients with suspected Dravet syndrome. EPILEPSY & BEHAVIOR. 2025; 167DOI:10.1016/j.yebeh.2025.110401. PMID:40158412. IF:2.300(Q2/4D).

01/06/2025 Telemedicine in critical care

Spies, CD, Ranzani, OT. Telemedicine in critical care. INTENSIVE CARE MEDICINE. 2025; 51(6)DOI:10.1007/s00134-025-07955-5. PMID:40471258. IF:21.200(Q1/1D).

01/06/2025 Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis

Paradies, V, Masiero, G, Rubboli, A, Van Beusekom, HMM, Costa, F, Capranzano, P, Degrauwe, S, Gorog, DA, Jorge, CM, Buchanan, GL, Alasnag, M, Trabattoni, D, Fraccaro, C, Sibbing, D, Dudek, D, Vilahur, G, Chieffo, A, Mehran, R, Capodanno, D, Barbato, E, Siller-Matula, JM. Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis. EuroIntervention. 2025; 21(12)DOI:10.4244/EIJ-D-24-00876. PMID:40388110. IF:9.500(Q1/1D).

01/06/2025 Comprehensive Clinical and Genetic Characterization of a Spanish Cohort of 22 Patients With Bainbridge-Ropers Syndrome

Trujillano, L, Valenzuela, I, Costa-Roger, M, Cusco, I, Fernandez-Alvarez, P, Cueto-Gonzalez, A, Lasa-Aranzasti, A, Masotto, B, Abuli, A, Codina-Sola, M, del Campo, M, Moreno, JAR, Dominguez, CP, Milla, CP, de la Fuente, RP, Quesada-Espinosa, JF, Nunez-Enamorado, N, Gener, B, Ballesta-Martinez, MJ, Brea-Fernandez, AJ, Fernandez-Prieto, M, Trujillo-Quintero, JP, Ruiz, A, Santos-Simarro, F, Rosello, M, Orellana, C, Martinez, F, Martinez-Monseny, AF, Casas-Alba, D, Serrano, M, Palomares-Bralo, M, Rikeros-Orozco, E, Gomez-Cano, MA, Tirado-Requero, P, Juste, JP, Ramos, FJ, Garcia-Arumi, E, Tizzano, EF. Comprehensive Clinical and Genetic Characterization of a Spanish Cohort of 22 Patients With Bainbridge-Ropers Syndrome. CLINICAL GENETICS. 2025; 107(6)DOI:10.1111/cge.14701. PMID:39833101. IF:2.300(Q3/6D).

01/06/2025 Effects of Chronic High-Fat Diet and Pemafibrate Treatment on Stroke Outcomes

Chaparro-Cabanillas, N, Pedragosa, J, Núñez-Moyano, H, Escolà-Gil, JC, Planas, AM. Effects of Chronic High-Fat Diet and Pemafibrate Treatment on Stroke Outcomes. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025; 45(1)DOI:. PMID:. IF:4.500(Q1/2D).

01/06/2025 Regression of pre-existing white matter hyperintensities after CD19 CAR Tcell induced ICANS: A case series

Borrell-Pichot, M, Lozano, A, Granell, E, Caballero, A, Briones-Mejide, J, Caballero-Avila, M, Vidal-Jordana, A, Querol, L, Mart n-Aguilar, L. Regression of pre-existing white matter hyperintensities after CD19 CAR Tcell induced ICANS: A case series. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Exploring results of mechanical thrombectomy in nonagenarians with ischaemic stroke and anterior circulation occlusion

Delgado-Romeu, M, Lopez-Lombardia,O, Carbonell-Fern ndez, P, Morales-Gonz lez, C, Borrell-Pic, M, Martinez-Dome o, A, Guasch-Jim nez, M, Ezcurra-D az, G, Fern ndez-Vidal, J, Prats-S nchez, L, Ramos-Pachn, A, Marti-Fabregas, J, Camps-Renom, P, Lambea-Gil, A. Exploring results of mechanical thrombectomy in nonagenarians with ischaemic stroke and anterior circulation occlusion. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Exploring gender disparities in neurology education: Insights from Spanish medical schools

Lambea-Gil, A, Gil-Navarro, S, Jim nez, M, Mart nez-S nchez, P, Mir, P, Oreja-Guevara, C, Pascual-Gomez, J, P rez-Sempere, A, Santos-Lasaosa, S, Frank-Garc a, A, D ez-Tejedor, E. Exploring gender disparities in neurology education: Insights from Spanish medical schools. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 End-of-life and palliative sedation in the neurology inpatient unit of a tertiary hospital

Morales-Gonz lez, C, Lambea-Gil, A, Barroeta-Espar, I, Olmedo-Saura, G, Prats-S nchez, L, Ramos-Pachon, A, Ros-Castello, V, Vesperina-Castro, A, Mart nez-Dome o, A. End-of-life and palliative sedation in the neurology inpatient unit of a tertiary hospital. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Neurophobia and the perception of neurology among neurologists in Spain

Saldana-Inda, I, Lambea-Gil, A. Neurophobia and the perception of neurology among neurologists in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Exploring the Association of Cerebral Vasoreactivity in Patients with Acute Intracerebral Hemorrhage with Functional Outcomes

García, JM, Gil, AL, Pachón, AR, Díaz, GE, Jiménez, MG, Renom, PC, Gómez, MI, Frisk, LK, Vega, CF, Zanoletti, M, Simón, AA, Fabrega, CG, Grifol, NP, Chorro, IM, Sánchez, LP, Vidal, JMF, Fernandez, JJS, Fabregas, JM, Durduran, T. Exploring the Association of Cerebral Vasoreactivity in Patients with Acute Intracerebral Hemorrhage with Functional Outcomes. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025; 45(1)DOI:. PMID:. IF:4.500(Q1/2D).

01/06/2025 Safety and efficacy data from the phase 2 ARDA study of empasiprubart in multifocal motor neuropathy

Querol, L, Harbo, T, Peric, S, Hussain, Y, Cadour, S, van de Walle, I, Persson, E, Vujcic, M, van de Steen, O, Allen, J, Orazio, EN, Attarian, S, Karam, C, Katzberg, H, Stettner, M, Rinaldi, S, van der Pol, W. Safety and efficacy data from the phase 2 ARDA study of empasiprubart in multifocal motor neuropathy. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Safety and efficacy of riliprubart in chronic inflammatory demyelinating polyneuropathy: 76-week phase 2 trial results

Querol, L, Lewis, RA, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Auwarter, K, Lu, Y, Alonso, MA, Atassi, N, Hughes, RAC. Safety and efficacy of riliprubart in chronic inflammatory demyelinating polyneuropathy: 76-week phase 2 trial results. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Effect of efgartigimod PH20 SC on lower limb function in chronic inflammatory demyelinating polyneuropathy in ADHERE

Rinaldi, S, Allen, J, Lin, J, Stettner, M, Merkies, I, Guptill, J, Hewamadduma, C, Istas, G, De Roeck, A, Kuwabara, S, Lauria, G, Querol, L, Suresh, N, Karam, C, Skripuletz, T, Echaniz-Laguna, A, Van Hoorick, B, Yamasaki, R, Lewis, R, van Doorn, P. Effect of efgartigimod PH20 SC on lower limb function in chronic inflammatory demyelinating polyneuropathy in ADHERE. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Proteomic profiling of Guillain-Barre Syndrome using aptamers: Identifying and Validating Potential Biomarkers

Collet-Vidiella, R, Aguilar, LM, Lleix , C, Caballero-Avila, M, Illa, CT, Go i, EP, Llarch, P, Lluci -Carol, L, Tous, MS, Casasnovas, C, Guti rrez-Guti rrez, G, Fern ndez, JP, Carbayo, A, Gallardo, E, Vesperinas, A, Llanso, L, Fern ndez-Cadenas, I, Querol, L. Proteomic profiling of Guillain-Barre Syndrome using aptamers: Identifying and Validating Potential Biomarkers. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Chat-GPT-4o in diagnosis and management of real-life polyneuropathy cases: Comparative analysis with neurologists

De Lorenzo, A, Moretti, G, Bertini, A, Collet-Vidiella, R, Fasolino, A, Fortanier, E, Hadden, R, Islam, B, Kleopa, K, Cejas, LL, Leonardi, L, Mira, V, Peric, S, Rajabally, Y, Sevilla, T, Tomaselli, P, Tozza, S, Pisciotta, C, Pareyson, D, Nobile-Orazio, E, Doneddu, P. Chat-GPT-4o in diagnosis and management of real-life polyneuropathy cases: Comparative analysis with neurologists. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Immune checkpoint inhibitor-related myositis-myasthenia: A retrospective cohort study in Spain

Hernandez, EM, Maqueda, JC, Fonseca, E, Marco, C, Chico, J, Fernandez, JG, Llaurado, A, Cabello, J, del Pino, L, Izquierdo, C, Cortes, E, G llego, J, Ros, M, Cald , R, Pelayo, A, Vizcaino, CS, Hernandez, H, Alvarez, J, Simo, M, Dalmau, J, Bruna, J, Velasco, R. Immune checkpoint inhibitor-related myositis-myasthenia: A retrospective cohort study in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Efficacy of Riliprubart in chronic inflammatory demyelinating polyneuropathy: Phase 2 subgroup analyses

Lewis, RA, Querol, L, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Lu, Y, Alonso, MA, Atassi, N, Hughes, AC. Efficacy of Riliprubart in chronic inflammatory demyelinating polyneuropathy: Phase 2 subgroup analyses. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Managing multifocal motor neuropathy: A survey of neurologists from Japan, Canada, and six European countries

Querol, L, Lewis, R, Sommer, C, Bromberg, M, Barrera-Sierra, S, Arvin-Berod, C, Nisbet, P, Gelinas, D, Guptill, J, Wood, J. Managing multifocal motor neuropathy: A survey of neurologists from Japan, Canada, and six European countries. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Psychometric evaluation of resistance to change questionnaire: reluctance to adopt new treatments in myasthenia gravis

Reyes, V, Maurino, J, Armangu , T, Querol, L, Guti rrez-Guti rrez, G, Sotoca, J, Ares, A, Villaverde, R, Salas, E, D az-Abos, P, Cort s-Vicente, E, Gomez-Ballesteros, R, Ballesteros, J. Psychometric evaluation of resistance to change questionnaire: reluctance to adopt new treatments in myasthenia gravis. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Quality of life in patients with generalised myasthenia gravis receiving rozanolixizumab: Post hoc analysis of MycarinG

Sacconi, S, Antozzi, C, Cortes-Vicente, E, Pascuzzi, R, Utsugisawa, K, Vissing, J, Vu, T, Bloemers, J, Grimson, F, Tarancon, T, Bril, V. Quality of life in patients with generalised myasthenia gravis receiving rozanolixizumab: Post hoc analysis of MycarinG. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Efgartigimod in pretreated patients with CIDP and progressive/relapsing or persistent disease activity

Skripuletz, T, Allen, J, Rinaldi, S, Lauria, G, Querol, L, Magy, L, De Roeck, A, Van Hoorick, B, Hofman, E, Istas, G, Stettner, M, Lewis, R, van Doorn, P. Efgartigimod in pretreated patients with CIDP and progressive/relapsing or persistent disease activity. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Assessment of patient-reported outcomes from the phase 3 vivacity-MG3 study of nipocalimab in gMG

Vicente, EC, Pease, S, Imran, N, Gandhi, K, Ait-Tihuaty, M, Turkoz, I, Coteur, G, Gary, C, Choudhry, Z, Ramchandran, S, Vissing, J. Assessment of patient-reported outcomes from the phase 3 vivacity-MG3 study of nipocalimab in gMG. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Herding-like behaviour in myasthenia gravis treatment decisions: exploring underlying mechanisms

Villaverde, R, Gomez-Ballesteros, R, Reyes, V, Armangue, T, Querol, L, Gutierrez-Gutierrez, G, Sotoca, J, Ares, A, Salas, E, Abos, PD, Squaglia, A, Maurino, J, Cortes-Vicente, E. Herding-like behaviour in myasthenia gravis treatment decisions: exploring underlying mechanisms. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: SELECTED SECONDARY OUTCOMES FROM THE ADHERE TRIAL

Lewis, RA, Suresh, N, Mazzeo, A, Allen, JA, Querol, L, Hussain, YM, Gwathmey, KG, Guptill, JT, Istas, G, Van Hoorick, B, Mole, T, Kuwabara, S, Basta, I, van Door, PA. SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: SELECTED SECONDARY OUTCOMES FROM THE ADHERE TRIAL. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

01/06/2025 EFFICACY OF RILIPRUBART IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: PHASE 2 SUBGROUP ANALYSES

Lewis, RA, Querol, L, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Lu, Y, Alonso, MA, Atassi, N, Hughes, RAC. EFFICACY OF RILIPRUBART IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: PHASE 2 SUBGROUP ANALYSES. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

01/06/2025 SAFETY AND EFFICACY OF RILIPRUBART IN CIDP 76-WEEK PHASE 2 TRIAL RESULTS

Falzone, Y, Querol, L, Lewis, R, Hartung, HP, van Doorn, P, Lin, J, Donnie, A, Attarian, S, Wallstroem, E, Auwarter, K, Lu, Y, Alonso, MA, Atassi, N, Hughes, R. SAFETY AND EFFICACY OF RILIPRUBART IN CIDP 76-WEEK PHASE 2 TRIAL RESULTS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

01/06/2025 CHAT-GPT-4O IN DIAGNOSIS AND MANAGEMENT OF REAL-LIFE POLYNEUROPATHY CASES: COMPARATIVE ANALYSIS WITH NEUROLOGISTS

De Lorenzo, A, Moretti, GS, Bertini, A, De Lorenzo, A, Vidiella, RC, Falzone, YM, Fortanier, E, Gendre, T, Gentile, F, Hadden, R, Islam, B, Kleopa, K, Cejas, LL, Leonardi, L, Mandia, D, Marion, M, Mira, V, Peric, S, Querol, L, Rajabally, Y, Sevilla, T, Tomaselli, PJ, Tozza, S, Bosca, M, Brouwer, M, Cocco, A, Cousyn, L, De Santis, T, Gonzalez, F, Lukic, MJ, Mistry, N, Maranzano, A, Morena, E, Nakano, FN, Saura, GO, Sechi, E, Ticozzi, N, Troisi, S, Tsokkos, T, Aymeric, W, Pisciotta, C, Orazio, EN, Pareyson, D, Doneddu, PE. CHAT-GPT-4O IN DIAGNOSIS AND MANAGEMENT OF REAL-LIFE POLYNEUROPATHY CASES: COMPARATIVE ANALYSIS WITH NEUROLOGISTS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

01/06/2025 EFFECT OF RITUXIMAB ON NEUROFILAMENT IN CIDP: DATA FROM THE CIDPRIT RANDOMIZED CONTROLLED TRIAL

Gallo, C, Doneddu, PE, Collet-Vidiella, R, Cocito, D, Manganelli, F, Falzone, Y, Pinter, GL, Benedetti, L, Mazzeo, A, Peci, E, Spina, E, Strano, C, Dalla Bella, E, Germano, F, Gentile, L, Liberatore, G, Cutellè, C, Bianchi, E, Querol, L, Nobile-Orazio, E. EFFECT OF RITUXIMAB ON NEUROFILAMENT IN CIDP: DATA FROM THE CIDPRIT RANDOMIZED CONTROLLED TRIAL. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

01/06/2025 EFFICACY AND SAFETY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS

Allen, JA, Door, PAV, Benedetti, L, Basta, I, Dysgaard, T, Eggers, C, Guptill, JT, Gwathmey, KG, Hewamadduma, C, Hofman, E, Hussain, YM, Kuwabara, S, Le Masson, G, Leypoldt, F, Lin, J, Lipowska, M, Lowe, M, Pinter, GL, Querol, L, Simu, MA, Chang, TN, Tse, A, Ulrichts, P, Van Hoorick, B, Yamasaki, R, Lewis, RA. EFFICACY AND SAFETY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

01/06/2025 Clinical spectrum of anti-IgLON5 disease: A case series with three distinct movement disorder phenotypes

Alberti-Vall, B, Olmedo-Saura, G, Domine, M, Borrell-Pichot, M, Avila, MC, Jordana, AV, Pagonabarraga-Mora, J, Kulisevsky, J, Perez, P. Clinical spectrum of anti-IgLON5 disease: A case series with three distinct movement disorder phenotypes. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

01/06/2025 Fast-track strategy to shorten hospital stay in acute complicated paediatric appendicitis: protocol of the FTAA clinical trial

Leganes, C, Zapata, MJM, Valle, JM, Membrilla, E, Bordon, EA, Palazón, P, Fortes, LM, Núñez, B, Alvarez, N, Pueyo, C, Soria, A, Oviedo, M, Delgado-Espinoza, CE, Antonijoan, RM. Fast-track strategy to shorten hospital stay in acute complicated paediatric appendicitis: protocol of the FTAA clinical trial. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

01/06/2025 Non-commercial sponsored clinical trials with medicinal products in Spain since CTIS implementation

Delgado-Espinoza, CE, Garcia, CP, Hosey, KA, Pestana, MJC, Lasso, LFC, Arbos, RMA. Non-commercial sponsored clinical trials with medicinal products in Spain since CTIS implementation. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

01/06/2025 Environmental impact of avoidable tertiary care: earth-caring arguments for decentralizing trials

Pontes, C, Cortes, M, Delgado, CE, Castillo, LF, Amaro, K, Torres, F, Antonijoan, RM. Environmental impact of avoidable tertiary care: earth-caring arguments for decentralizing trials. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

01/06/2025 Increasing use of gabapentinoids out of their authorised indications

Pontes, C, Cortés, M, de Pando, T, Gomez-Oliveros, B, Antonijoan, RM, Carot-Sans, G, Ramiro, M. Increasing use of gabapentinoids out of their authorised indications. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

01/06/2025 Rising alarm on strong opioids in the elderly: a description of utilization and prescription characteristics

Navarro, TDP, Perez, AM, Carot-Sans, G, Martinez, LE, Belis, MV, Nadal, AM, Garcia, CP. Rising alarm on strong opioids in the elderly: a description of utilization and prescription characteristics. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

01/06/2025 On the complexity of biomarker-driven diagnoses of Alzheimer's disease

Grasso, SM, Santos-Santos, MA, Clark, AL. On the complexity of biomarker-driven diagnoses of Alzheimer's disease. Journal of Neuropsychology. 2025; 19(2)DOI:10.1111/jnp.12428. PMID:40317662. IF:1.800(Q3/6D).

01/06/2025 City PROFILE: "Barcelona: The experience of 40 years of health reports, a health for all policies tool"

Borrell, C, Carrere, J, Rodríguez-Sanz, M, Gomez-Gutiérrez, A, Daban, F, Pérez, G, Artazcoz, L, Pasarín, MI, Bartoll-Roca, X, Sánchez-Ledesma, E, Serral, G, Mari-Dell'Olmo, M, Montalvo, T, Pérez, K. City PROFILE: "Barcelona: The experience of 40 years of health reports, a health for all policies tool". CITIES. 2025; 161DOI:10.1016/j.cities.2025.105862. PMID:. IF:6.600(Q1/1D).

01/06/2025 Surgical Approach to Hidradenitis Suppurativa

Mateu-Arrom, L, Puig, L, Vilarrasa, E. Surgical Approach to Hidradenitis Suppurativa. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2024.10.061. PMID:40185225. IF:(Q/D).

01/06/2025 The Y chromosome: male reproduction and beyond

Krausz, C, Abrardo, C. The Y chromosome: male reproduction and beyond. FERTILITY AND STERILITY. 2025; 123(6)DOI:10.1016/j.fertnstert.2025.03.006. PMID:40064392. IF:7.000(Q1/1D).